Since the U.S. Securities and Exchange Commission approved the first wave of spot Bitcoin ETFs in January 2024, investors have gained regulated, exchange-listed access to the asset class without managing wallets or private keys. ARKB and IBIT stand out as two of the more prominent vehicles in this space. They do not hold overlapping equity portfolios or follow different thematic approaches, yet they compete directly for the same core objective: low-friction exposure to Bitcoin’s spot price. Comparing them comes down less to strategy differences and more to execution details such as cost, custody, liquidity, and scale, which can influence long-term results even when the underlying asset remains the same.
The ARK 21Shares Bitcoin ETF (ARKB) is a passively managed, spot Bitcoin exchange-traded product sponsored by 21Shares US LLC, with ARK Investment Management LLC acting as sub-adviser. It aims to track Bitcoin’s performance against the CME CF Bitcoin Reference Rate – New York Variant, after expenses and liabilities. ARKB operates as a grantor trust holding Bitcoin directly rather than futures or derivatives, so each share corresponds to a fractional interest in the trust’s holdings. The portfolio is essentially 100% Bitcoin, with minimal cash for operations. It trades on the Cboe BZX Exchange with a sponsor fee of 0.21%, the lowest among leading spot Bitcoin ETFs at launch. Bitcoin is custodied across multiple qualified providers, and shares are created and redeemed in large blocks. As a buy-and-hold vehicle, it avoids active trading, leverage, or income strategies. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.
The iShares Bitcoin Trust ETF (IBIT) is BlackRock’s spot Bitcoin exchange-traded product under the iShares brand. Like ARKB, it is a passive grantor trust seeking to mirror Bitcoin’s price using the same CME CF Bitcoin Reference Rate – New York Variant benchmark. IBIT holds actual Bitcoin in custody with Coinbase Custody Trust Company and uses The Bank of New York Mellon for cash custody. Its structure is likewise nearly 100% Bitcoin. The sponsor fee stands at 0.25%, and the fund trades on Nasdaq. What sets IBIT apart is its scale: it has become the largest spot Bitcoin ETF by assets under management and ranks among the most actively traded in the category, aided by BlackRock’s distribution reach and institutional ties. This liquidity profile typically supports tighter bid-ask spreads and smoother price discovery.
Both funds operate within the digital-asset sector and face the same macro and regulatory influences. The approval of spot Bitcoin ETFs represented a key structural shift, giving registered investment advisers, pension funds, and brokerage platforms compliant access they previously lacked. Ongoing U.S. regulatory clarity around custody and creation-redemption mechanics continues to shape the category. Bitcoin’s price remains sensitive to interest-rate expectations, dollar strength, and overall risk sentiment, while ETF inflows have emerged as an important supply-side factor. Sector risks stay significant, including sharp drawdowns, custody concentration, and an evolving adoption path. For ARKB and IBIT alike, these forces are identical; the distinction lies in how each issuer handles access, custody, and distribution.
Because ARKB and IBIT track the same asset and benchmark, their returns have shown strong correlation in recent periods, moving in tandem with Bitcoin’s cycles of gains and pullbacks. The main ongoing performance difference stems from fees: ARKB’s 0.21% expense ratio versus IBIT’s 0.25% allows ARKB to capture a slightly larger portion of Bitcoin’s return over time, all else equal. That said, IBIT holds an edge in liquidity and scale. Its higher trading volume and narrower spreads can lower effective transaction costs, especially for larger or institutional orders, which may offset the modest fee gap. ARKB’s cost advantage tends to appeal more to infrequent traders with a long-term horizon. Volatility and drawdown profiles are essentially the same for both, given their single-asset concentration in a high-volatility holding.
Considering structural factors, cost, liquidity, and trend alignment, Tickeron’s AI would likely lean toward IBIT for investors focused on execution quality and scale, while recognizing ARKB’s fee benefit for cost-conscious, long-term holders. IBIT’s stronger liquidity, institutional reach, and tighter spreads help reduce friction, particularly in volatile conditions. ARKB’s lower 0.21% expense ratio offers a real, compounding advantage for buy-and-hold investors who trade less often. Overall, the assessment tilts toward IBIT for broad robustness, though ARKB remains a solid option when minimizing fees takes priority.
I often turn to Tickeron’s AI Screener when evaluating ETFs like these. It lets me apply filters for technical patterns, volatility, and performance metrics across thousands of assets, helping surface relevant comparisons more efficiently than manual checks. The tool has become a regular part of how I refine ideas before making allocation decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
IBIT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 23 instances where the indicator turned negative. In 22 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The 10-day RSI Indicator for IBIT moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 22 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBIT as a result. In 61 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
IBIT moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 50-day moving average for IBIT moved above the 200-day moving average on October 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBIT advanced for three days, in 171 of 190 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
IBIT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 137 of 160 cases where IBIT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.